![James Hill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
James Ferguson Hill served as Non-Executive Chairman at Genetix Group Ltd. from 2000 to 2010.
He was also Director & Senior VP-Corporate Affairs at SmithKline Beecham Ltd. from 1994 to 2001.
Currently, he is an Independent Director at Akari Therapeutics Plc, a position he has held since 2015 and will hold until 2023.
Ehemalige bekannte Positionen von James Hill
| Unternehmen | Position | Ende |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Direktor/Vorstandsmitglied | 30.06.2023 |
Genetix Group Ltd.
 Genetix Group Ltd. Medical SpecialtiesHealth Technology Provides solutions for imaging and intelligent image analysis in the life science and diagnostic markets | Vorsitzender | 14.01.2010 |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2001 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Provides solutions for imaging and intelligent image analysis in the life science and diagnostic markets | Health Technology |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
